Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Correction: Brolucizumab—early real-world experience: BREW study

The Original Article was published on 24 July 2020

Correction to: Eye

https://doi.org/10.1038/s41433-020-1111-x

Since online publication of this article, the authors became aware of two errors in the text of the manuscript:

  1. 1.

    Page 1 Paragraph 1, an incorrect approval date was inserted. The correct sentence is provided below:

    Brolucizumab (Beovu, Novartis, Basel, Switzerland) is the newest anti-vascular endothelial growth factor (anti-VEGF) drug. lt was approved for the treatment of neovascular age-related macular degeneration (nAMD) by the US-FDA on October 7, 2019, followed by the European Commission’s approval for use in the European Union on February 13, 2020.

  2. 2.

    Page 2 Paragraph 1, an incorrect percentage was provided. The correct sentence is provided below:

Pigment epithelial detachment (PED) was present in 31 eyes (73.8%) at baseline and resolved in 2 eyes (6.4%), was reduced in 13 eyes (41.9%\, and did not show any change in 16 eyes (51.6%) (Fig. 1).

The authors apologise for any inconvenience caused.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ashish Sharma.

Additional information

The original article can be found online at https://doi.org/10.1038/s41433-020-1111-x.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Sharma, A., Kumar, N., Parachuri, N. et al. Correction: Brolucizumab—early real-world experience: BREW study. Eye 35, 1286 (2021). https://doi.org/10.1038/s41433-020-01351-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41433-020-01351-7

Search

Quick links